Kobiolabs, Inc.

13 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Sep 2036

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due May 21, 2027
The maintenance fee for Lactobacillus Gasseri KBL697 Strain and Use Thereof (US 11,819,526) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
1 fee due Aug 20, 2027
The maintenance fee for Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community (US 11,903,980) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 12,070,477	Lactobacillus sp. strain having ability to inhibit growth of vaginal pathogenic microorganisms In force Term ends Sep 26, 2036 · From the USPTO record	In force	Term ends Sep 26, 2036	From the USPTO record
US 11,365,452	Composition for Diagnosing or Predicting Risk of Metabolic Syndrome or Metabolic Syndrome-Related Diseases Using Human Oral Microbiome In force Term ends Nov 15, 2037 · High confidence	In force	Term ends Nov 15, 2037	High confidence
US 11,903,980	Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community In force Term ends Sep 28, 2038 · From the USPTO record	In force	Term ends Sep 28, 2038	From the USPTO record
US 11,602,552	Lactobacillus Plantarum KBL396 Strain and Use Thereof In force Term ends Feb 23, 2039 · High confidence	In force	Term ends Feb 23, 2039	High confidence
US 11,510,948	Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community In force Term ends Mar 30, 2039 · From the USPTO record	In force	Term ends Mar 30, 2039	From the USPTO record
US 11,291,698	Lactobacillus Paracasei Strain and Use Thereof In force Term ends May 9, 2039 · High confidence	In force	Term ends May 9, 2039	High confidence
US 11,992,511	Lactobacillus Paracasei Strain and Use Thereof In force Term ends May 9, 2039 · High confidence	In force	Term ends May 9, 2039	High confidence
US 11,141,444	Lactobacillus Crispatus KBL693 Strain and Use Thereof In force Term ends May 23, 2039 · High confidence	In force	Term ends May 23, 2039	High confidence
US 11,285,183	Lactobacillus Gasseri KBL697 Strain and Use Thereof In force Term ends May 23, 2039 · High confidence	In force	Term ends May 23, 2039	High confidence
US 11,633,439	Lactobacillus Crispatus KBL693 Strain and Use Thereof In force Term ends May 23, 2039 · High confidence	In force	Term ends May 23, 2039	High confidence

10 of 13 patents shown.

Pro members see all 13.

Pro members: see all 13 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 1 abandoned · 2 no status recorded

List them